127 related articles for article (PubMed ID: 29893883)
1. Effect of continuous intravenous oxycodone infusion in opioid-naïve cancer patients with dyspnea.
Yamamoto Y; Watanabe H; Sakurai A; Deguchi Y; Hirano S; Okumura Y; Kumon A; Watanabe N; Osada T; Yamamura K; Odagiri T
Jpn J Clin Oncol; 2018 Aug; 48(8):748-752. PubMed ID: 29893883
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: a retrospective study.
Kawabata M; Kaneishi K
Am J Hosp Palliat Care; 2013 May; 30(3):305-11. PubMed ID: 22669937
[TBL] [Abstract][Full Text] [Related]
3. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
Maeda T; Hayakawa T
J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
[TBL] [Abstract][Full Text] [Related]
4. How Successful Is Parenteral Oxycodone for Relieving Terminal Cancer Dyspnea Compared With Morphine? A Multicenter Prospective Observational Study.
Mori M; Kawaguchi T; Imai K; Yokomichi N; Yamaguchi T; Suzuki K; Matsunuma R; Watanabe H; Maeda I; Uehara Y; Morita T;
J Pain Symptom Manage; 2021 Aug; 62(2):336-345. PubMed ID: 33290857
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of opioid switching for dyspnea and its predictors in cancer patients: a single-center retrospective observational study.
Yamamoto Y; Tanaka S; Matsuura K; Yamamoto S; Urano K; Okita J; Kato E; Odagiri T; Deguchi Y
Jpn J Clin Oncol; 2024 May; 54(5):549-555. PubMed ID: 38323655
[TBL] [Abstract][Full Text] [Related]
6. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians.
Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H
J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
Shinjo T; Okada M
Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
[TBL] [Abstract][Full Text] [Related]
8. Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study.
Mori M; Yamaguchi T; Suzuki K; Matsuda Y; Matsunuma R; Watanabe H; Ikari T; Matsumoto Y; Imai K; Yokomichi N; Miwa S; Yamauchi T; Okamoto S; Inoue S; Inoue A; Hui D; Morita T; Satomi E;
J Pain Symptom Manage; 2023 Aug; 66(2):e177-e184. PubMed ID: 37080479
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.
Lazzari M; Greco MT; Marcassa C; Finocchi S; Caldarulo C; Corli O
Drug Des Devel Ther; 2015; 9():5863-72. PubMed ID: 26586937
[TBL] [Abstract][Full Text] [Related]
10. Analgesic Effect of Intraoperative Intravenous S-Ketamine in Opioid-Naïve Patients After Major Lumbar Fusion Surgery Is Temporary and Not Dose-Dependent: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Brinck ECV; Maisniemi K; Kankare J; Tielinen L; Tarkkila P; Kontinen VK
Anesth Analg; 2021 Jan; 132(1):69-79. PubMed ID: 32167978
[TBL] [Abstract][Full Text] [Related]
11. Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients.
Takeyasu M; Miyamoto A; Kato D; Takahashi Y; Ogawa K; Murase K; Mochizuki S; Hanada S; Uruga H; Takaya H; Morokawa N; Kishi K
Intern Med; 2016; 55(7):725-9. PubMed ID: 27041155
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective study on intravenous compound injection of cancer pain patients with oxycodone and hydrocotarnine preparation in comparison with subcutaneous administration].
Sano T; Akagi T; Yokote N; Shuto C; Kudo N; Miura K; Murakami S; Saito O; Yamamoto H; Matoba M
Gan To Kagaku Ryoho; 2012 May; 39(5):769-75. PubMed ID: 22584329
[TBL] [Abstract][Full Text] [Related]
13. Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain.
Ravera E; Di Santo S; Bosco R; Arboscello C; Chiarlone R
Aging Clin Exp Res; 2011; 23(5-6):328-32. PubMed ID: 22526067
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Oxycodone for Dyspnea in End-stage Heart Failure with Renal Insufficiency.
Tanaka M; Maeba H; Senoo T; Iwasaka J; Ohkita A; Kita H; Uchitani K; Hirota Y
Intern Med; 2018 Jan; 57(1):53-57. PubMed ID: 29033442
[TBL] [Abstract][Full Text] [Related]
15. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
Kopecky EA; Vaughn B; Lagasse S; O'Connor M
Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
[TBL] [Abstract][Full Text] [Related]
16. [Piritramide versus oxycodone for patient-controlled intravenous analgesia. Opioid-induced side effects].
Sebastian H
Schmerz; 2014 Dec; 28(6):614-21. PubMed ID: 25179415
[TBL] [Abstract][Full Text] [Related]
17. Oxycodone frequently induced nausea and vomiting in oxycodone-naïve patients with hepatic dysfunction.
Igarashi T; Abe K; Miura T; Tagami K; Motonaga S; Ichida Y; Hasuo H; Matsumoto Y; Saito S; Kinoshita H
J Palliat Med; 2015 May; 18(5):399. PubMed ID: 25806647
[No Abstract] [Full Text] [Related]
18. Continuous local bupivacaine wound infusion with neuraxial morphine reduces opioid consumption after cesarean delivery.
Zaretsky M; Wood C; Nivens T; McLaughlin G; Zuk J; Pan Z; Chow F
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3895-3902. PubMed ID: 29848107
[No Abstract] [Full Text] [Related]
19. Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?
Kanbayashi Y; Hosokawa T
J Palliat Med; 2014 Jun; 17(6):683-7. PubMed ID: 24702605
[TBL] [Abstract][Full Text] [Related]
20. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.
Silvestri B; Bandieri E; Del Prete S; Ianniello GP; Micheletto G; Dambrosio M; Sabbatini G; Endrizzi L; Marra A; Aitini E; Calorio A; Garetto F; Nastasi G; Piantedosi F; Sidoti V; Spanu P
Clin Drug Investig; 2008; 28(7):399-407. PubMed ID: 18544000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
